For the experimental validation, we chose aggressive cell lines from liver (Hep3B, Huh‐7), breast (MDA‐MB‐231), and colorectal (SW480, SW620) cancers to create ZEB1 overexpression models. The gene discussed is ZEB1; the disease is cancer.